These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8037585)

  • 1. [Expression and co-expression of cellular oncogenes in the course of tumor progression in neuroendocrine lung tumors].
    Kogan EA; Shtabskiĭ AB; Sekamova SM; Sukhova NM; Mazurenko NN
    Arkh Patol; 1994; 56(2):16-21. PubMed ID: 8037585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peripheral small cell carcinoma, atypical and typical lung carcinoids (morphologic features, cell oncogene expression, DNA histospectrophotometry)].
    Kogan EA; Sekamova SM; Mazurenko NN; Bogatyrev VN
    Arkh Patol; 1991; 53(7):42-8. PubMed ID: 1683768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
    Wang DG; Johnston CF; Buchanan KD
    Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunohistochemistry of cellular oncogenes in precancer and cancer of the lung].
    Kogan EA; Mazurenko NN; Iushkov PV; Trishkina NV; Kiselev FL
    Arkh Patol; 1990; 52(8):3-11. PubMed ID: 2281984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nuclear oncoprotein expression in lung precancer and cancer at various stages of tumor progression studies at the level of light- and electron-immunohistochemistry].
    Kogan EA; Shtabskiĭ AB; Sekamova SM; Mazurenko NN; Kiselev FL
    Arkh Patol; 1994; 56(6):44-9. PubMed ID: 7605217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis and distribution of oncoproteins in tumor tissue].
    Mazurenko NN; Kogan EA; Sukhova NM; Zborovskaia IB
    Vopr Med Khim; 1991; 37(6):53-9. PubMed ID: 1839874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung.
    Dosaka-Akita H; Cagle PT; Hiroumi H; Fujita M; Yamashita M; Sharma A; Kawakami Y; Benedict WF
    Cancer; 2000 Feb; 88(3):550-6. PubMed ID: 10649246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
    Bolon I; Gouyer V; Devouassoux M; Vandenbunder B; Wernert N; Moro D; Brambilla C; Brambilla E
    Am J Pathol; 1995 Nov; 147(5):1298-310. PubMed ID: 7485393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cell oncogene expression in normal, metaplastic, dysplastic epithelium and squamous cell carcinoma of the uterine cervix].
    Petrov SV; Mazurenko NN; Sukhova NM; Moroz IP; Katsenel'son VM; Raĭkhlin NT; Kiselev FL
    Arkh Patol; 1994; 56(4):22-31. PubMed ID: 7848100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
    Wang DG; Johnston CF; Sloan JM; Buchanan KD
    J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the L-myc gene is under positive control by short-lived proteins.
    Saksela K
    Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the pro-opiomelanocortin gene in lung neuroendocrine tumours: in situ hybridization and immunohistochemical studies.
    Black M; Carey FA; Farquharson MA; Murray GD; McNicol AM
    J Pathol; 1993 Mar; 169(3):329-34. PubMed ID: 8388056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.